---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-378505"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2026-09-01T20:37:04+00:00"
generated_at: "2026-09-01T20:38:11.310714+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Moderna closes $3.0B 0% convertible notes due 2032; conversion at $210.58

## Summary
- $3.0B aggregate 0.00% convertible senior notes due 2032; conversion price $210.58 (47.5% premium to $142.77).
- Net proceeds ~$2,957.3M; $328.8M used for capped call transactions, rest for oncology growth and debt repayment.
- Capped calls cap price $392.62/share (175% premium), reducing dilution on conversion.
- Notes convertible into up to 14,246,100 shares initially; max 21,012,600 in limited cases.

## SEC filing metadata
- accession: 0001193125-26-378505
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2026-09-01T20:37:04+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/0001193125-26-378505-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000119312526378505/d108896d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-378505
- JSON: https://secwatch.observer/filing/0001193125-26-378505.json
- Plain text: https://secwatch.observer/filing/0001193125-26-378505.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.